Form EFFECT LUMOS PHARMA, INC.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2024 |
| Accession Number: | 0001193125-24-276551 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Conversation with CHAI AI: $100M ARR, App Store Review, and what motivates AI research
- KKR Leads A$400 Million Financing Solution for Ampol
- ELEKTROS Celebrates Continued Market Strength and Reaffirms Its Strategic Vision for Next-Generation EV Charging
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
